A Systematic Review and Evidence-based Analysis of Ingredients in Popular Male Fertility Supplements.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 09 09 2019
revised: 09 09 2019
accepted: 07 11 2019
pubmed: 21 11 2019
medline: 28 2 2020
entrez: 21 11 2019
Statut: ppublish

Résumé

To study the level of evidence available for ingredients of popular over-the-counter male fertility supplements. The top 17 male fertility supplements in the United States were identified from the most popular online retailers: A1 Supplements, Amazon, Vitamin Shoppe, and Walmart. Individual ingredients were identified for each supplement. The PUBMED and Cochrane online databases were reviewed for randomized controlled trials studying the efficacy of each ingredient. Each ingredient was categorized based on availability of evidence using an adapted version of the scoring system by the American Heart Association. Scores were assigned to each categorical level of evidence for each ingredient and a composite score for each supplement was calculated. Ninety unique ingredients were identified. The 5 most commonly used ingredients were vitamin E, folic acid, zinc, vitamin C, and selenium whereas the 5 ingredients with most evidence were L-carnitine, Vitamin E, Vitamin C, CoQ10, and Zinc. In all, only 22% of ingredients used were found to have published evidence for improvement in semen parameters and only 17% of ingredients had data published showing a positive effect. Our evidence-based analysis demonstrated an average composite rating of 1.66 (on a scale to 5). Evolution 60 and Conception XR had the highest composite scores with 3.6 and 3.5, respectively. Many male fertility supplements claim to improve fertility; however, their products are rarely backed by evidence and their efficacy remains unproven. Few ingredients used in popular fertility supplements have positive evidence in randomized clinical trials and should therefore be used cautiously.

Identifiants

pubmed: 31747549
pii: S0090-4295(19)31006-4
doi: 10.1016/j.urology.2019.11.007
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-141

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Manish Kuchakulla (M)

Department of Urology, Miller School of Medicine, University of Miami, Miami, FL.

Yash Soni (Y)

Department of Urology, Miller School of Medicine, University of Miami, Miami, FL.

Premal Patel (P)

Department of Urology, Miller School of Medicine, University of Miami, Miami, FL.

Neel Parekh (N)

Department of Urology, Cleveland Clinic, Cleveland, OH.

Ranjith Ramasamy (R)

Department of Urology, Miller School of Medicine, University of Miami, Miami, FL. Electronic address: Ramasamy@miami.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH